Testing effectiveness (Phase 2)Study completedNCT00005056What this trial is testingBryostatin 1 In Treating Patients With Progressive Kidney CancerWho this might be right forKidney Cancer Cancer Research UK
Not applicableLooking for participantsNCT05334069What this trial is testingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more Alliance for Clinical Trials in Oncology 2,000
Large-scale testing (Phase 3)Study completedNCT00002473What this trial is testingKidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney CancerWho this might be right forKidney Cancer European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00378703What this trial is testingBevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7 National Cancer Institute (NCI) 361
Very early researchStudy completedNCT00405366What this trial is testingSorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney CancerWho this might be right forKidney Cancer UNC Lineberger Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04473781What this trial is testingInterstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerWho this might be right forStage I Renal Cell CancerStage II Renal Cell Cancer Jonsson Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT06447103What this trial is testingAn Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more Jonsson Comprehensive Cancer Center 91
Not applicableEnded earlyNCT00727532What this trial is testingSorafenib in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forHereditary Clear Cell Renal Cell CarcinomaKidney Cancer Northwestern University 9
Testing effectiveness (Phase 2)Ended earlyNCT03334409What this trial is testingPazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more Academic and Community Cancer Research United 5
Early research (Phase 1)Ended earlyNCT02595918What this trial is testingNivolumab in Treating Patients With High-Risk Kidney Cancer Before SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage I Renal Cell Cancer AJCC v6 and v7+3 more National Cancer Institute (NCI) 19
Early research (Phase 1)Active Not RecruitingNCT01590069What this trial is testingAerosolized Aldesleukin in Treating Patients With Lung MetastasesWho this might be right forMetastatic Malignant Neoplasm in the LungMetastatic MelanomaMetastatic Osteosarcoma+5 more M.D. Anderson Cancer Center 70
Not applicableWithdrawnNCT01769885What this trial is testingTivozanib Before Surgery in Treating Patients With Localized Kidney CancerWho this might be right forStage II Renal Cell CancerStage III Renal Cell Cancer Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT00365157What this trial is testingEribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney DysfunctionWho this might be right forAdvanced Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Urothelial Carcinoma+4 more National Cancer Institute (NCI) 132
Large-scale testing (Phase 3)Looking for participantsNCT05987241What this trial is testingTesting the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial Carcinoma+4 more National Cancer Institute (NCI)
Not applicableStudy completedNCT00458484What this trial is testingRadiosurgery in Treating Patients With Kidney TumorsWho this might be right forKidney Cancer Case Comprehensive Cancer Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07037004What this trial is testingAdding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After SurgeryWho this might be right forClear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more City of Hope Medical Center 62
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00019955What this trial is testingRadiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)Who this might be right forKidney Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00121251What this trial is testingSorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7Stage IV Renal Cell Cancer AJCC v7 National Cancer Institute (NCI) 17